1. Home
  2. KBDC vs CERT Comparison

KBDC vs CERT Comparison

Compare KBDC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kayne Anderson BDC Inc.

KBDC

Kayne Anderson BDC Inc.

HOLD

Current Price

$14.00

Market Cap

941.8M

Sector

N/A

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$6.53

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBDC
CERT
Founded
2021
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
941.8M
1.1B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
KBDC
CERT
Price
$14.00
$6.53
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$15.40
$12.22
AVG Volume (30 Days)
406.3K
3.3M
Earning Date
03-02-2026
05-04-2026
Dividend Yield
13.59%
N/A
EPS Growth
N/A
87.50
EPS
1.67
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
$193.84
$5.05
Revenue Next Year
$9.00
$5.73
P/E Ratio
$8.38
N/A
Revenue Growth
N/A
8.75
52 Week Low
$13.06
$6.04
52 Week High
$16.89
$15.38

Technical Indicators

Market Signals
Indicator
KBDC
CERT
Relative Strength Index (RSI) 52.70 35.76
Support Level $13.54 $6.04
Resistance Level $14.33 $7.52
Average True Range (ATR) 0.36 0.36
MACD 0.04 0.03
Stochastic Oscillator 82.03 17.77

Price Performance

Historical Comparison
KBDC
CERT

About KBDC Kayne Anderson BDC Inc.

Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: